Atlas Trials

Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer

Clinical trial NCT06430658 · RECRUITING

Trial details

NCT number
NCT06430658
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Esophagus Cancer
Start date
2024-04-01
Primary completion
2026-12-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.